NASDAQ:NRC National Research (NRC) Stock Price, News & Analysis $20.78 +0.43 (+2.11%) Closing price 04:00 PM EasternExtended Trading$20.80 +0.02 (+0.12%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About National Research Stock (NASDAQ:NRC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get National Research alerts:Sign Up Key Stats Today's Range$20.22▼$21.1550-Day Range$18.30▼$22.3452-Week Range$11.01▼$23.68Volume117,687 shsAverage Volume125,508 shsMarket Capitalization$472.75 millionP/E Ratio83.12Dividend Yield3.08%Price Target$26.00Consensus RatingModerate Buy Company Overview National Research Corporation, formerly traded on the Nasdaq under the symbol NRC and known as NRC Health, provides market research, analytics and performance-improvement services to healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers understand the experiences and expectations of patients, employees, physicians and communities. The company’s offerings have included patient-experience measurement, employee and physician engagement surveys, reputation and brand research, community health assessments, data analytics and advisory services. NRC Health combines survey programs, benchmarking data and technology tools to help healthcare organizations improve service quality, strengthen relationships with stakeholders and support strategic decision-making. Founded in 1981 and headquartered in Lincoln, Nebraska, the company served healthcare organizations in the United States and other markets. National Research Corporation was acquired by Press Ganey in 2021 and became part of Press Ganey’s healthcare experience and improvement platform. The business is now generally identified as NRC Health rather than as an independent publicly traded company.AI Generated. May Contain Errors. Read More National Research Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreNRC MarketRank™: National Research scored higher than 61% of companies evaluated by MarketBeat, and ranked 331st out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingNational Research has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.Upside PotentialNational Research has a consensus price target of $26.00, representing about 25.1% upside from its current price of $20.78.Amount of Analyst CoverageNational Research has only been the subject of 2 research reports in the past 90 days.Read more about National Research's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of National Research is 83.12, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.95.Price to Earnings Ratio vs. SectorThe P/E ratio of National Research is 83.12, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.64.Price to Book Value per Share RatioNational Research has a P/B Ratio of 33.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about National Research's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.32% of the float of National Research has been sold short.Short Interest Ratio / Days to CoverNational Research has a short interest ratio ("days to cover") of 5.93.Change versus previous monthShort interest in National Research has recently increased by 7.65%, indicating that investor sentiment is decreasing significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldNational Research pays a meaningful dividend of 3.14%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthNational Research does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of National Research is 256.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about National Research's dividend. News and Social Media3.5 / 5News Sentiment0.55 News SentimentNational Research has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for National Research this week, compared to 1 article on an average week.Search Interest8 people have searched for NRC on MarketBeat in the last 30 days. This is an increase of 700% compared to the previous 30 days. Company Ownership0.9 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, National Research insiders have not sold or bought any company stock.Percentage Held by Insiders9.20% of the stock of National Research is held by insiders.Percentage Held by Institutions47.26% of the stock of National Research is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about National Research's insider trading history. Receive NRC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRC Stock News HeadlinesNational Research (NASDAQ:NRC) Stock Price Breaks Above Two Hundred Day Moving Average - What's Next?October 1, 2026 | americanbankingnews.comFormer U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027September 30, 2026 | globenewswire.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.October 5 at 1:00 AM | Banyan Hill Publishing (Ad)Mercy Earns National Honor for Excellence in Patient ExperienceSeptember 1, 2026 | prnewswire.comRecord Backlog Powers NRC Health’s (NRC) Upward PotentialAugust 10, 2026 | insidermonkey.comNational Research: Q2 Earnings SnapshotJuly 30, 2026 | finance.yahoo.comNRC Health (NRC) Q2 2026 Earnings Call TranscriptJuly 29, 2026 | seekingalpha.comNRC Health Announces Second Quarter 2026 ResultsJuly 28, 2026 | businesswire.comSee More Headlines NRC Stock Analysis - Frequently Asked Questions How have NRC shares performed this year? National Research's stock was trading at $18.77 on January 1st, 2026. Since then, NRC stock has increased by 10.7% and is now trading at $20.78. How were National Research's earnings last quarter? National Research Corporation (NASDAQ:NRC) announced its earnings results on Tuesday, July, 28th. The company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $0.46. The firm had revenue of $35.39 million for the quarter, compared to analyst estimates of $34.90 million. National Research had a trailing twelve-month return on equity of 164.26% and a net margin of 4.18%. Read the conference call transcript. Does National Research have any subsidiaries? The following companies are subsidiaries of National Research: PatientWisdom Inc., The Governance Institute, and National Research Corporation Canada. How do I buy shares of National Research? Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some other companies that National Research investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Alphabet (GOOG), Netflix (NFLX), Advanced Micro Devices (AMD) and JPMorgan Chase & Co. (JPM). Company Calendar Record date for 7/10 Dividend6/26/2026Ex-Dividend for 7/10 Dividend6/26/2026Dividend Payable7/10/2026Last Earnings7/28/2026Record date for 10/9 Dividend9/25/2026Ex-Dividend for 10/9 Dividend9/25/2026Today10/05/2026Dividend Payable10/09/2026Next Earnings (Estimated)10/26/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 NRC's financial health is in the Green zone, according to TradeSmith. NRC has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:NRC CIK70487 Webwww.nrchealth.com Phone(402) 475-2525Fax402-475-9061Employees357Year Founded1981Price Target and Rating Average Price Target for National Research$26.00 High Price Target$26.00 Low Price Target$26.00 Potential Upside/Downside+25.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.25 Trailing P/E Ratio83.12 Forward P/E RatioN/A P/E GrowthN/ANet Income$11.60 million Net Margins4.18% Pretax Margin6.70% Return on Equity164.26% Return on Assets14.67% Debt Debt-to-Equity Ratio13.13 Current Ratio0.65 Quick Ratio0.65 Sales & Book Value Annual Sales$137.39 million Price / Sales3.44 Cash Flow$1.28 per share Price / Cash Flow16.18 Book Value$0.62 per share Price / Book33.52Miscellaneous Outstanding Shares22,750,000Free Float20,653,000Market Cap$472.75 million OptionableOptionable Beta0.25 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:NRC) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
